Composition for prevention and treatment on viral infectious myocarditis
A technology for viral infection and myocarditis, applied in the field of medicine, can solve the problems of non-specific treatment methods, etc., and achieve the improvement of biochemical indicators, significant effect, and good biochemical indicators
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0012] The above description is only an overview of the technical solution of the present invention. In order to understand the technical means of the present invention more clearly and implement it according to the content of the description and conventional technical means in the field, the animal test examples of the present invention will be further described in detail below .
[0013] The preparation method of the compound Trefolane A involved in the present invention can be found in the literature (Trefolanes A–D with aDiterpene-Sesquiterpene Skeleton from Supercritical Fluid Extracts of Helianthus annuus L.var.AriannaOrg.Lett., 2015, 17(19), 4730–4733).
[0014] Tubeimoside A, CAS: 102040-03-9, is available in the market.
[0015] Modeling: 4-week-old clean-grade mice, weighing 7-11g, male, the ambient temperature of the animal room is 27°C-30°C, and the humidity is 35%-45%. 616 mice were randomly divided into 22 groups, 28 in each group, divided into 20 groups of drug...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com